Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
Novo Shares Drop as Ozempic Pill Fails Alzheimer’s Trial
Posted
November 24, 2025
Views
1,668
Likes
11
Comments
1
Engagement
November 24, 2025
1,668
11
1
0.72%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
6:37Now PlayingMadison Muller, Bloomberg News health reporter, says that the failure of a long-shot trial to see if the pill form of Novo Nordisk's weight loss drug Ozempic impacted Alzheimer's was the latest in a long string of disappointments for investors into the pharmaceutical company. Novo Nordisk is down over 50% on the year.
pill version of Novo Nordisk A/S’s Ozempic failed to slow the progression of Alzheimer’s disease in a pair of long-shot studies that aimed to open up a new use for blockbuster obesity drugs.
Patients who took the medicine didn’t see their disease progress more slowly based on a cognitive assessment, the Danish drugmaker said Monday. Novo will discontinue a planned one-year extension of the studies. The stock closed down 5.8% in Copenhagen at the lowest level in more than four years.
The failure removes one of the last remaining hopes for a near-term revival under new Chief Executive Officer Mike Doustdar, though Novo had described the Alzheimer’s trials as an outside chance. The company is struggling to regain its footing after losing the top spot in the obesity market to Eli Lilly & Co.
“It was a lottery ticket that could have had great value,” said Per Hansen, investment economist at Nordnet AB. “Investors hadn’t assigned it any real value. Still, the hope was there.”
--------
Watch Bloomberg Radio LIVE on YouTube
Weekdays 7am-6pm ET
Follow us on X
Subscribe to our Podcasts:
Bloomberg Daybreak
Bloomberg Surveillance
Bloomberg Intelligence
Balance of Power
Bloomberg Businessweek
Listen on Apple CarPlay and Android Auto with the Bloomberg Business app:
Apple CarPlay
Android Auto
Visit our YouTube channels:
Bloomberg Podcasts
Bloomberg Television
Bloomberg Originals
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
